MLB has released a statement about the Miami New Times story. Nothing unexpected. I will say, though, that the shoutout to the Mitchell Report made me laugh. Nothing makes the p.r-motivated superficiality of the Mitchell Report any clearer than seeing a story like this one. At the time they crowed about the Mitchell Report as being a thorough accounting. As I’ve written many times before, it … was not.
Anyway, from MLB:
“We are always extremely disappointed to learn of potential links between players and the use of performance-enhancing substances. These developments, however, provide evidence of the comprehensive nature of our anti-drug efforts. Through our Department of Investigations, we have been actively involved in the issues in South Florida. It is also important to note that three of the players allegedly involved have already been disciplined under the Joint Drug Program.
“The recommendations of the Mitchell Report have once again played a critical role in Major League Baseball’s ongoing efforts against performance-enhancing drugs. MLB implemented all of the recommendations made by Senator Mitchell in 2007, several of which emphasized the significance of installing proactive investigative services.
“The establishment of our Department of Investigations has represented a critical advance in these comprehensive efforts. In the years since its formation, DOI’s work has proven pivotal to bringing to light information regarding the use of performance-enhancing substances. Furthermore, DOI has built strong working relationships with federal and local law enforcement authorities. These relationships are crucial because only law enforcement officials have the capacity to reach those outside the game who are involved in the distribution of illegal performance-enhancing drugs.
“Vigilance remains the key toward protecting the integrity of our game. We have the best and most stringent drug testing policy in professional sports, we continue to work with our doctors and trainers to learn what they are seeing day-to-day and we educate our players about the game’s unbending zero-tolerance approach. We remain fully committed to following all leads and seeking the appropriate outcomes for all those who use, purchase and are involved in the distribution of banned substances, which have no place in our game.
“We are in the midst of an active investigation and are gathering and reviewing information. We will refrain from further comment until this process is complete.”
Matt Hague got a cup of coffee in Toronto this year after winning the International League MVP, but the 30-year-old first baseman/third baseman found a better opportunity in Japan and the Blue Jays have sold him to the Hanshin Tigers.
Hague hit .338 in 136 games at Triple-A this past season and is a career .301 hitter in eight minor-league seasons overall, but his lack of power limits his opportunities in the majors and he’s received a grand total of 91 plate appearances as a big leaguer.
Ben Nicholson-Smith of Toronto Sportnet reports that the sale price for Hague is $300,000, which goes to the Blue Jays. And then Hague will no doubt sign a deal for a lot more than he could have earned at Triple-A and perhaps more than the MLB minimum salary.
The Arizona Diamondbacks just announced that have traded righty Allen Webster to the Pirates for cash considerations.
Webster, who turns 26 in February, was DFA’d by the Dbacks a few days ago. He pitched in nine games, starting five, in 2015, posting a 5.81 ERA and a K/BB ratio of 17/20 (eww) in 31 innings. Before that he pitched 89.1 innings for the Red Sox over two years with numbers not too terribly more impressive than that.
Joel Sherman of the New York Post reports that the Yankees “have let teams know Ivan Nova is available” in trade.
Nova returned from Tommy John elbow surgery in May to throw 94 innings with a 5.07 ERA and will be a free agent after the 2016 season, so it’s tough to imagine his trade market being particularly robust.
Despite that, Sherman writes that the Yankees “are not selling low” on Nova and might try to package him with other players to bring back a young starting pitcher under team control for multiple seasons. In other words, they’d like to trade Nova for a pitcher who can step into his rotation spot in 2016 and beyond.
Nova has had some good years in New York, but he’s 29 years old with a career 4.33 ERA and just 6.7 strikeouts per nine innings. He’s more middle-of-the-rotation starter than front-line starter and even that might be in question following elbow surgery.
All offseason there have been reports that the Marlins are looking to trade 25-year-old outfielder Marcell Ozuna because he’s fallen out of favor with the organization and specifically owner Jeffrey Loria.
And now Jerry Crasnick of ESPN.com reports that the Mariners “are working on a trade” for Ozuna, speculating that they’re offering a starting pitcher such as Nate Karns or Roenis Elias. MLB.com Marlins beat writer Joe Frisaro says “nothing is imminent” with an Ozuna trade but “everything is subject to change.”
Karns or Elias alone would seem like a light return for Ozuna, who’s hit .265 with 36 homers and a .727 OPS through 346 career games as a big leaguer and put up good numbers in the minors. He’s a plus defensive corner outfielder with 25-homer power under team control through 2019. There’s value there, whether Loria likes him or not.
But then again if the Marlins are dead set on parting ways with Ozuna perhaps new Mariners general manager Jerry Dipoto is taking advantage by swooping in with a mediocre offer. Or maybe that was the initial proposal and the Marlins are currently holding out for James Paxton or Taijuan Walker?